← back to search

Eduard Bentea

Allen Institute for Brain Science · US
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Neuroscience and Neuropharmacology Research, Parkinson's Disease Mechanisms and Treatments, Amino Acid Enzymes and Metabolism, and Tryptophan and brain disorders.
h-index
20
citations
1,082
works
103
NIH funding
primary concept
email

Recent publications

Absence of Ledgf in mouse brain affects the Kmt2a/b and polycomb balance, synaptic transmission and motor function
Acta Neuropathologica Communications 2026cited by 0position: middledoi
Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and parkinsonian motor deficits
Acta Neuropathologica 2025cited by 1position: middledoi
The G2019S LRRK2 mutation exacerbates α-synuclein and tau neuropathology through divergent pathways in Parkinson’s disease models
Acta Neuropathologica 2025cited by 1position: middledoi
Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and Parkinsonian motor deficits
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 0position: middledoi
Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia
Journal of Neural Transmission 2022cited by 4position: middledoi
Rodent models based on endolysosomal genes involved in Parkinson's disease
Current Opinion in Neurobiology 2021cited by 7position: middledoi
Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter
Molecular Psychiatry 2020cited by 40position: firstdoi
Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia
Scientific Reports 2019cited by 72position: middledoi
Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia
Molecular Omics 2019cited by 53position: firstdoi
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments
Molecular Neurobiology 2018cited by 53position: middledoi
Absence of system xc − on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis
Journal of Neuroinflammation 2017cited by 31position: middledoi
Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein
Frontiers in Behavioral Neuroscience 2015cited by 52position: firstdoi
Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed
The Journal of Comparative Neurology 2015cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Veerle Baekelandt · Allen Institute for Brain Science6 papers (2015–2026)Robert E. McCullumsmith · University of Alabama at Birmingham5 papers (2018–2022)María Sanchiz-Calvo · Allen Institute for Brain Science4 papers (2021–2025) · 4 papers (2018–2022) · 4 papers (2015–2020) · 4 papers (2018–2020)Chris Van den Haute · Allen Institute for Brain Science4 papers (2024–2026)George Tsafaras · Allen Institute for Brain Science3 papers (2024–2025)Diego Cabezudo · Allen Institute for Brain Science3 papers (2024–2025) · 3 papers (2015–2017) · 3 papers (2015–2017) · 3 papers (2018–2020)Jarek Meller · Cincinnati Children's Hospital Medical Center3 papers (2018–2022) · 3 papers (2015–2020)Giulia Albertini · VIB-KU Leuven Center for Cancer Biology3 papers (2015–2017)Zhexing Wen · Emory University3 papers (2018–2019)Thomas Demuyser · University of Antwerp3 papers (2015–2017)Teresa Torre-Muruzabal · Allen Institute for Brain Science2 papers (2024–2025)Gustavo Morrone Parfitt · Allen Institute for Brain Science2 papers (2024–2025)Lut Arckens · Allen Institute for Brain Science2 papers (2015–2020)